News Release

Printer Friendly Version View printer-friendly version
<< Back
Adoption grows for Allscripts cutting edge Prescription Price Transparency Solution
Incorporates real-time price data into prescribing workflow

CHICAGO, Sept. 05, 2018 (GLOBE NEWSWIRE) -- Allscripts (NASDAQ: MDRX), a global leader in healthcare information technology, is delivering comprehensive prescription price information directly into the clinicians’ workflow. Allscripts Prescription Price Transparency (PPT) empowers physicians and their patients with real-time comprehensive drug price information, at the point of patient care, designed to optimize the clinical and financial impact of each prescription. Allscripts PPT adoption has been rapid, already with more than 20,000 providers utilizing the system to date in 2018, processing nearly 8M transactions covering more than 1.1M patients.

Patients are bearing more of the cost for their own healthcare than ever before. As a result, they are increasingly demanding to know the cost of a service or product prior to it being administered. This has led to greater physician demand for new ways to more effectively manage the medication cost conversation with their patients.
  
“By making it as easy as possible for partners to integrate their data, Allscripts has delivered a price transparency solution that includes the broadest range of partners,” says Jill Helm, PharmD, vice-president of business development for Allscripts Payer and Life Sciences. “This enables physicians to provide as many patients as possible with the information they need to make an informed decision. Combined with providing visibility into both insured and uninsured drug prices, as well as alternative therapies and pharmacies, this uniquely comprehensive solution is already being used for more than one million monthly transactions.”   

Allscripts Prescription Price Transparency (PPT) works with partner companies including health plans, Pharmacy Benefit Managers (PBM), and others to deliver real-time information at the point of prescription, including:

  • Medication price from the health plan or pharmacy benefit manager
  • Pharmacy cash price with or without discounts
  • Competitive prices at different pharmacies
  • Cost of potential alternate therapies

Physicians employing Allscripts PPT empower patients to confidently ask about their medication cost, work together to determine an optimal care plan that is cost effective, and select a pharmacy location that is convenient.    

Allscripts PPT automatically embeds real-time prescription pricing information into the e-prescribing workflow, enabling healthcare providers to see what patients will pay for their medication. Healthcare providers can optimize patient care planning by quickly and easily explaining appropriate options for potential savings or discounts based on the patients’ needs.

“Along with our partners, Allscripts is excited to be the first to deliver these sought-after capabilities to healthcare professionals,” said Tom Langan, CEO of Allscripts Payer and Life Sciences organization. “Prescription Price Transparency is just the first in a series of innovations from Allscripts, as we move toward providing real-time health insights that can help providers take patient care to the next level. By seamlessly integrating real-time data and valuable information into the provider’s existing workflow, these solutions help them identify opportunities to optimize patient engagement, reduce patient cost, and enhance medication adherence.”  

ENDS

About Allscripts
Allscripts (NASDAQ: MDRX) is a leader in healthcare information technology solutions that advance clinical, financial and operational results. Our innovative solutions connect people, places and data across an Open, Connected Community of Health™. Connectivity empowers caregivers to make better decisions and deliver better care for healthier populations. To learn more, visit www.allscripts.com, Twitter, YouTube and It Takes A Community: The Allscripts Blog.

© 2018 Allscripts Healthcare, LLC and/or its affiliates. All Rights Reserved.

Allscripts, the Allscripts logo, and other Allscripts marks are trademarks of Allscripts Healthcare, LLC and/or its affiliates. All other products are trademarks of their respective holders, all rights reserved. Reference to these products is not intended to imply affiliation with or sponsorship of Allscripts Healthcare, LLC and/or its affiliates.

For more information contact:

Investors:
Stephen Shulstein
312-386-6735
Stephen.Shulstein@allscripts.com

Media:
Concetta Rasiarmos
312-447-2466
concetta.rasiarmos@allscripts.com

Allscripts-Logo.png

Stock Information

Featured Events

  Q2 2018 Earnings Press Release

  Q2 2018 - Supplemental Financial Data

Transfer Agent Info:

For questions about your shares or address changes, please
click here for more information.